Skip to main content
Clinical Trials/NCT04522258
NCT04522258
Completed
Not Applicable

Effects of Dietary Fiber on Affective Processes

KU Leuven1 site in 1 country70 target enrollmentMay 2, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emotions
Sponsor
KU Leuven
Enrollment
70
Locations
1
Primary Endpoint
Stress sensitivity (cortisol)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The effects of dietary fiber on psychobiological processes are examined in a sample of healthy volunteers.

Detailed Description

The study is an interventional triple-blind, placebo-controlled, parallel group design with 2 arms (placebo, dietary fiber). Healthy male participants adhere to their normal eating habits for the duration of the study (32 days). At the baseline study visit, measurements are taken in the lab, including biological samples and psychophysiological measurements. Participants then consume placebo or dietary fiber for 4 weeks and revisit the lab on day 32 for a second measurement of the outcomes of interest. Specifically, we investigate the effect of dietary fiber on affective processing, including stress sensitivity and fear-related processes (e.g. extinction learning). Volunteers also respond to questionnaires in relation to mood and GI symptoms, and provide biological samples (saliva, blood, faecal, and urine samples) for analysis of cortisol levels, circulating short chain fatty acids and serum BDNF, faecal SCFA and microbiota composition, and intestinal permeability, respectively.

Registry
clinicaltrials.gov
Start Date
May 2, 2019
End Date
November 8, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Kristin Verbeke

Prof. Dr. Kristin Verbeke

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Male participants
  • Age range 20-40 years
  • BMI range 18.5-27
  • Dutch or English as native-language

Exclusion Criteria

  • previous or current neurological, psychiatric, gastrointestinal or endocrine disorders, or other relevant medical history
  • current or recent regular medication use
  • previous or current substance/alcohol dependence or abuse (\> 2 units per day/14 units per week)
  • one or more diagnoses based on the mini-international neuropsychiatric interview
  • night-shift work
  • adherence to vegan or vegetarian diets
  • use of pre- or probiotics within one month preceding the study
  • use of antibiotics within 3 months preceding the study
  • Habitual diet not exceeding consumption of 25 g of dietary fiber per day
  • previous experience with one of the tasks used in the study

Outcomes

Primary Outcomes

Stress sensitivity (cortisol)

Time Frame: through study completion, on average 1 year and 5 months

Induction of cognitive, physical, and social stress using Maastricht Acute Stress Test. Stress hormone cortisol is quantified by gathering multiple saliva samples throughout the stress induction and recovery during both pre-intervention and post-intervention visit.

Secondary Outcomes

  • Stress sensitivity (subjective)(through study completion, on average 1 year and 5 months)
  • Cortisol awakening response(through study completion, on average 1 year and 5 months)
  • Perceived Stress Scale (PSS)(through study completion, on average 1 year and 5 months)
  • Fear(through study completion, on average 1 year and 5 months)
  • Positive and Negative Affect Schedule (PANAS)(through study completion, on average 1 year and 5 months)
  • Serum SCFA(through study completion, on average 1 year and 5 months)
  • Faecal SCFA(through study completion, on average 1 year and 5 months)
  • Fear (subjective)(through study completion, on average 1 year and 5 months)
  • Serum BDNF(1 year and 5 months)
  • Depression, anxiety, and stress scales (DASS-21)(through study completion, on average 1 year and 5 months)
  • Leiden Index of Depression Sensitivity-Revised (LEIDS-R)(through study completion, on average 1 year and 5 months)
  • Gastrointestinal symptom rating scale (GSRS)(through study completion, on average 1 year and 5 months)
  • Intestinal permeability(through study completion, on average 1 year and 5 months)

Study Sites (1)

Loading locations...

Similar Trials